Microarray determined "high" vs. "low" transcript levels for the eight NFκB and AP-1 regulated genes variably expressed in the 54 UCSF breast cancer cases were evaluated in relation to patient relapse-free survival (RFS), adjusted for prior adjuvant tamoxifen use and patient age-at-diagnosis. The gene discussed is NFKB1; the disease is breast cancer.